Stocks
Health Care
cntb
Connect Biopharma Holdings
NASDAQ: CNTB
+0.70 (+33.18%)
2.81
USD
At close at Nov 28, 21:44 UTC
Overview
Loading chart...
Key Stats
Market Cap
82.79M
Dividend Yield
0.00%
P/E Ratio
-4.86
EPS
-3.67
Revenue
26.03M
Avg. Volume
839.77K
Recently from Cashu
No Cashu articles
Connect Biopharma Holdings currently has no Cashu-related articles
About
What does CNTB do?
Connect Biopharma Holdings, based in San Diego, develops therapies for T cell-driven inflammatory diseases and went public on March 19, 2021. Its lead candidates include rademikibart for atopic dermatitis and asthma, and icanbelimod for ulcerative colitis.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.